Learn about Hemoglobin

Aims and scope

Hemoglobin is a journal in the English language for the communication of research and information concerning hemoglobin in humans and other species. Hemoglobin publishes articles, reviews, points of view

The journal covers topics such as:

structure, function, genetics and evolution of hemoglobins
biochemical and biophysical properties of hemoglobin molecules
characterization of hemoglobin disorders (variants and thalassemias),
consequences and treatment of hemoglobin disorders
epidemiology and prevention of hemoglobin disorders (neo-natal and adult screening)
modulating factors
methodology used for diagnosis of hemoglobin disorders

You will benefit from publishing in  Hemoglobin:

Having your work featured in one of the most well-established and highly regarded journals in the field of hemoglobin
Evaluating your work by the experienced members of our Editorial Board
Receiving 50 free e-prints and tips on promoting your article courtesy of Author Services
Increasing the discoverability of your research with Scopus listings and more
Tracking downloads, citations, and the Altmetric Score of your article on My Authored Works
Gaining recognition from an international audience
Increasing your opportunities for future collaboration

Peer Review Policy: All research articles in this journal have undergone rigorous peer review, based on initial editor screening and anonymous peer review.

Journal metrics

Usage

36K annual downloads/views

Citation metrics

1.2 (2023) Impact Factor
1.1 (2023) 5 year IF
1.7 (2023) CiteScore (Scopus)
0.487 (2023) SNIP
0.274 (2023) SJR

Speed/acceptance

20 days avg. from submission to first decision
36 days avg. from submission to first post-review decision
13 days avg. from acceptance to online publication
26% acceptance rate

Understanding and using journal metrics

Journal metrics can be a useful tool for readers, as well as for authors who are deciding where to submit their next manuscript for publication. However, any one metric only tells a part of the story of a journal’s quality and impact. Each metric has its limitations which means that it should never be considered in isolation, and metrics should be used to support and not replace qualitative review.

We strongly recommend that you always use a number of metrics, alongside other qualitative factors such as a journal’s aims & scope, its readership, and a review of past content published in the journal. In addition, a single article should always be assessed on its own merits and never based on the metrics of the journal it was published in.

For more details, please read the Author Services guide to understanding journal metrics.

Journal metrics in brief

Usage and acceptance rate data above are for the last full calendar year and are updated annually in February. Speed data is updated every six months, based on the prior six months. Citation metrics are updated annually mid-year. Please note that some journals do not display all of the following metrics (find out why).

Usage: the total number of times articles in the journal were viewed by users of Taylor & Francis Online in the previous calendar year, rounded to the nearest thousand.

Citation Metrics

Impact Factor*: the average number of citations received by articles published in the journal within a two-year window. Only journals in the Clarivate Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*: the journal’s highest subject category ranking in the Journal Citation Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*: the average number of citations received by articles in the journal within a five-year window.
CiteScore (Scopus)†: the average number of citations received by articles in the journal over a four-year period.
CiteScore Best Quartile†: the journal’s highest CiteScore ranking in a Scopus subject category. Q1 = 25% of journals with the highest CiteScores.
SNIP (Source Normalized Impact per Paper): the number of citations per paper in the journal, divided by citation potential in the field.
SJR (Scimago Journal Rank): Average number of (weighted) citations in one year, divided by the number of articles published in the journal in the previous three years.

Speed/acceptance

From submission to first decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision. Based on manuscripts receiving a first decision in the last six months.
From submission to first post-review decision: the average (median) number of days for a manuscript submitted to the journal to receive a first decision if it is sent out for peer review. Based on manuscripts receiving a post-review first decision in the last six months.
From acceptance to online publication: the average (median) number of days from acceptance of a manuscript to online publication of the Version of Record. Based on articles published in the last six months.
Acceptance rate: articles accepted for publication by the journal in the previous calendar year as percentage of all papers receiving a final decision.

For more details on the data above, please read the Author Services guide to understanding journal metrics.

*Copyright: Journal Citation Reports®, Clarivate Analytics
†Copyright: CiteScore™, Scopus

Editorial board

Editor-in-Chief
Adekunle Adekile - Safat, Kuwait
E-mail: [email protected]

Past Editors-in-Chief
Henri Wajcman - Hôpital Henri Mondor, France
Titus H.J. Huisman - Augusta, GA, USA
Abdullah Kutlar - Augusta, GA, USA

Associate Editors
Bassam Ali - Al-Ain, United Arab Emirates
Kenneth Ataga - Memphis, TN, USA
Reena Das - Chandigarh, India
Petros Kountouris - Nicosia, Cyprus
George P. Patrinos - Patras, Greece
Joanne Traeger-Synodinos - Athens, Greece
Farrukh Shah - London, UK

Editorial Board
Nicholas P. Anagnou - Athens, Greece
Shoaib A. Zadjali- Muscat, Oman
Samir K. Ballas - Philadelphia, PA, USA
Véronique Baudin-Creuza - Créteil, France
Erol Baysal - Dubai, UAE
Roshan B. Colah - Mumbai, India
Dong-Zhi Li - Guangzhou, People's Republic of China
Mohsen A.F. El-Hazmi - Riyadh, Saudi Arabia
Suthat Fucharoen - Bangkok, Thailand
Loïc Garçon - Amiens, France
Piero C. Giordano - Leiden, The Netherlands
Teruo Harano - Okayama, Japan
Cornelis L. Harteveld - Leiden, The Netherlands
Robert P. Hebbel - Minneapolis, MN, USA
Douglas R. Higgs - Oxford, UK
Achille Iolascon - Naples, Italy
Andreas E. Kulozik - Berlin, Germany
Abdullah Kutlar - Augusta, GA, USA
Lucio Luzatto - Genoa, Italy
Hossein Najmabadi - Tehran, Iran
John M. Old - Oxford, UK
Serge Pissard - Créteil, France
Jacques Rochette - Amiens, France
Martin H. Steinberg - Boston, MA, USA
Hannah Tamary - Petah-Tikva, Israel
Swee Lay Thein - Bethesda, MD, USA
Joan-Lluis Vives-Corrons - Barcelona, Spain
John S. Waye - Hamilton, ON, Canada

Updated 06-02-2024

Abstracting and indexing

Hemoglobin is included in the following abstracting and indexing services: EMBASE/Excerpta Medica; MEDLINE/Index Medicus; Science Citation Index Expanded™; Current Contents: Clinical Medicine

Open access

Hemoglobin is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article

Article Publishing Charges (APC)

If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.

Use our APC finder to calculate your article publishing charge

Advertising information

Would you like to advertise in Hemoglobin?

Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Hemoglobin.

Explore advertising solutions

Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .

Citation search

Jump to section

About this journal

Aims and scope

Journal metrics

Understanding and using journal metrics

Journal metrics in brief

Citation Metrics

Speed/acceptance

Editorial board

Abstracting and indexing

Open access

Why choose open access?

Article Publishing Charges (APC)

Advertising information

Would you like to advertise in Hemoglobin?

Ready to submit?

Information for

Open access

Opportunities

Help and information

Citation search

Your download is now in progress and you may close this window

Login or register to access this feature

About this journal

Aims and scope

Journal metrics

Understanding and using journal metrics

Journal metrics in brief

Citation Metrics

Speed/acceptance

Editorial board

Abstracting and indexing

Open access

Why choose open access?

Article Publishing Charges (APC)

Publication details

Advertising information

Would you like to advertise in Hemoglobin?

Ready to submit?

Information for

Open access

Opportunities

Help and information

Keep up to date